
Nine years ago, Professor Diana Hargreaves embarked on a V Foundation-funded project to find better drug targets for cancers with mutations in a multi-protein complex called SWI/SNF that regulates DNA structure and stability. Today, that project's exceptional success is being recognized with another V Foundation recognition—a 2025 All-Star Translational Award. Diana will receive $1 million to advance her new project, which aims to improve immunotherapy in patients with pancreatic cancer. Read more here: salk.edu/news-release/salk-p… #VictoryOverCancer #CancerResearch #SalkInstitute





















